Загрузка...
Selecting Frontline Therapy for CLL in 2018
The treatment landscape of chronic lymphocytic leukemia (CLL) has changed dramatically in the last few years. The role of chemoimmunotherapy has declined significantly for patients with CLL. Fludarabine, cyclophosphamide, rituximab chemotherapy remains the standard frontline therapy for young fit pa...
Сохранить в:
| Опубликовано в: : | Hematology Am Soc Hematol Educ Program |
|---|---|
| Главный автор: | |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Society of Hematology
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6245995/ https://ncbi.nlm.nih.gov/pubmed/30504317 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|